Visiox Pharma Appoints Ryan S. Bleeks as Chief Executive Officer

Visiox Pharma announced the appointment of Ryan S. Bleeks as Chief Executive Officer.

"We are excited to have Ryan join Visiox at this critical time for the organization," said Michael Derby, Visiox's Founding Investor and Executive Chairman. "His proven leadership in building teams, company infrastructure and executing successful launch strategies in the ophthalmics space will be instrumental as we accelerate our path towards commercialization."

"I am thrilled to build a business for the future that brings meaningful solutions to providers and patients while establishing Visiox's commitment to Ophthalmics," said Mr. Bleeks. "As we prepare for launch, we will continue to build a robust pipeline though the acquisition of early and late-stage assets."

Most recently Mr. Bleeks was the Vice President of Sales, Sales Training and Sales Operations at RVL Pharmaceuticals, where he was responsible for building the infrastructure, sales force and launch execution of Upneeq, the first product to treat acquired blepharoptosis in adults with a prescription cash pay strategy. Prior, he was the National Sales Director at Sun Pharma responsible for the successful launches of Cequa and Xelpros. Mr. Bleeks brings more than two decades of commercial experience, built on deep relationships in ophthalmology and optometry, which he established while launching more than 12 products in the eyecare space.

Visiox plans to submit two new drug applications to the FDA later this year in the glaucoma and cataract surgery markets. The company's lead candidate, PDP-716, is a novel once daily brimonidine formulation utilizing its patented TearAct delivery technology, which provides slow, consistent and sustained release for IOP control throughout the day. SDN-037 is a twice daily topical difluprednate corticosteroid utilizing the company's patented TJM (Tight Junction Modulation) Micellar platform. The novel technology provides powerful post-surgical control of inflammation in a clear solution enabling convenient dosing with a proven active ingredient.